Seaport Therapeutics Q3 net loss widens 17% to $26.39 million
Story updates
12:13:58 PM UTC
SquawkNews
*--Earnings Flash (SPTX) Seaport Therapeutics Posts Q3 Loss $0.49 a Share, vs. FactSet Est of $0.57 Loss
Related stories
SS&C Allocates $240 Million Term Loan, Launches $500 Million Syndication
SS&C Technologies said it allocated a $240 million term loan and launched a $500 million syndication.
M impact | EQUITY | Nov 02, 2026, 01:10 PM UTC
Tectonic Metals intersects 5.61 g/t gold over 41.15 meters
Tectonic Metals reported an intersection of 5.61 g/t gold over 41.15 meters at the Black Creek target of its Flat project.
M impact | EQUITY | Nov 02, 2026, 01:10 PM UTC
Nasdaq single-stock trading halt continues, symbol not given — reason not given (8:05 AM ET)
Nasdaq kept trading halted in a single listed security (reason not given) at 8:05 AM ET.
M impact | EQUITY | Nov 02, 2026, 01:09 PM UTC
China Lead to Sell 584.5 Million Shares at HK$0.242 Minimum
China Lead plans to sell 584.5 million shares at no less than HK$0.242 each.
L impact | EQUITY | Nov 02, 2026, 01:09 PM UTC
Bentley Systems subsidiary Seequent acquires Eliis
Seequent, a Bentley Systems subsidiary, has acquired Eliis.
M impact | EQUITY | Nov 02, 2026, 01:08 PM UTC
Marriott Raises Full-Year Revenue per Room Forecast on Resilient Travel Demand
M impact | EQUITY | Nov 02, 2026, 01:08 PM UTC